By Josh White
Date: Friday 09 May 2025
(Sharecast News) - Oxford BioDynamics announced on Friday that its Oxford-based laboratory had been accredited by the UK Accreditation Service (UKAS) as a clinical facility under ISO 15189, enabling it to process 'EpiSwitch' clinical tests in the UK.
By Josh White
Date: Wednesday 12 Feb 2025
(Sharecast News) - Oxford BioDynamics announced on Wednesday that it has signed a distribution agreement with Regina Maria, Romania's largest private healthcare provider, to offer its EpiSwitch PSE and CiRT blood tests to physicians and patients across the country.
By Josh White
Date: Wednesday 05 Feb 2025
(Sharecast News) - Oxford BioDynamics announced the publication of a multi-institutional clinical study on Wednesday, confirming the accuracy of its EpiSwitch Colorectal No-Stool Test (NST) in detecting colorectal cancer and precancerous polyps using a blood sample.
Currency | UK Pounds |
Share Price | 0.33p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 8.69 |
52 Week Low | 0.30 |
Volume | 7,829,247 |
Shares Issued | 1,957.58m |
Market Cap | £6.36m |
Beta | 0.00 |
Value | ![]() |
---|
Price Trend | ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:26 | 34 @ 0.30p |
15:45 | 9,439 @ 0.32p |
15:40 | 595,000 @ 0.31p |
11:20 | 40,665 @ 0.32p |
10:54 | 200,000 @ 0.32p |
You are here: research